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ABSTRACT
Some novel transition metal [Co(ll), Cu(ll), Ni(ll) and Zn(ll)] complexes of substituted pyridine Schiff-bases
have been prepared and characterized by physical, spectral and analytical data. The synthesized Schiff-bases
act as deprotonated tridentate for the complexation reaction with Co(ll), Ni(ll) and Zn(ll) ions. The new
compounds, possessing the general formula [M(L)2] where [M=Co(II), Cu(II), Ni(II) and Zn(II) and
HL=HL, HL-’, HL and HL4] show an octahedral geometry. In order to evaluate the effect of metal ions upon
chelation, the Schiff bases and their complexes have been screened for antibacterial activity against the
strains such as Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. The complexed
Schiff bases have shown to be more antibacterial against one more bacterial species as compared to
uncomplexed Schiff-bases.
INTRODUCTION
Much attention
’8 has been devoted by bioinorganic as well as by medicinal chemists to the relationship
between the metal ions and their complexes as antitumour
9- and antibacterial
35 agents. In vivo studies
have indicated that some biologically active compounds may become more carcinostatic and bacteriostatic
upon chelationS622. Such interactions of transition metal ions with amino acids, peptides and nucleic acids,
are of immense biological importance23"25. Several reviews
26"29 showed that the metallo-organic chemistry of
$30-33 such compounds greatly influence their biological action hghlghtng the catalytic function metal in
many biological processes
34"37
Several studies have revealed
38"39 that by condensation of salicylaldehyde with different heterocyclic
compounds, derivatives with potent antibacterial and antifungal activity are obtained. Osman et al
4 prepared
thiadiazole derived compounds of salicylaldehyde which were found to be highly potent antibacterial against
Bacilhts cereus and antifungal, against Aspergillus niger. Several compounds
4 incorporating piperazinyl
guanidine, when condensed with sa[icy[aldehyde were found to exhibit cardiovascular and vasodepressive
activity. Studies of Shah et a[42 also showed thiazolidinone-derived salicylaldehydes to possess good
antimicrobial activity. Keeping in view the significance of metals in biology, we have previously reported
4347
several series of biologically active compounds and have evaluated the role of metal ions on their biological
activity. In continuation to the same research topic, we report here some novel substituted pyridine Schiff
bases obtained from salicylaldehyde. We have also studied the effect of substituents as well as metals ions on
the biological activity of these derivatives.
EXPERIMENTAL
Material and Methods
All chemicals and solvents used were of Analar grade. All metal(II) salts were used as chlorides IR spectra
were recorded on a Philips Analytical PU 9800 FTIR spectrophotometer. UV-Visible spectra were obtained
in DMF on a Hitachi U-2000 double-beam spectrophotometer. C, H and N analyses was carried out by
Butterworth Laboratories Ltd. Conductance of the metal complexes was determined in DMF on a Hitachi
YSI-32 model conductometer. Magnetic measurements were made on solid complexes using the Gouy
method. Melting points were recorded on a Gallenkamp apparatus and are uncorrected.
HL. R=OH
HL2: R=NO)
HL3: R=OCITt
HE4: R=Br
(Fig. 1) Structure of the Schiffbases
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Preparation of Schiff base (HL)
Salicylaldehyde (1.2 g, 1.1 mL, 0.01 M) in ethanol (10 mL) was added to an ethanol solution (20 mL) of 2-
amino-5-hydroxypyridine (1.0 g, 0.01 M). Then 2-3 drops of conc.H2SO4 were added and the mixture
refluxed for 2 h. On cooling, a solid product was formed which was filtered, washed with ethanol, then with
ether and dried. Crystallization from hot ethanol gave HL. The same method was applied for the preparation
of HL2, HL and HL by using the corresponding reagents in the same molar ratio.
Preparation of cobalt(ll)complex of HL
A warm ethanol solution (20 mL) of HL (0.4 g, 0.002 M) was added to a magnetically stirred solution of
cobalt chloride hexahydrate (0.24 g, 0.001 M) in distilled water (25 mL). The mixture was refluxed for h
and cooled to room temperature. On cooling, pink precipitates were formed which were filtered, washed with
ethanol, acetone and ether, and dried by suction. Crystallization from aqueous ethanol (30:70) gave the
desired metal complex (1). All other metal complexes were prepared respectively following the same method.
Antibacterial studies
The synthesized metal complexes, in comparison to the uncomplexed Schiff-bases were screened for their
antibacterial activity against pathogenic bacterial strains, Escherichia coli, Staphylococcus aureus and
Pseudomonas aeruginosa. The paper disc diffusion method
4s49 reported elsewhere was adopted for the
determination of antibacterial activity.
RESULTS AND DISCUSSION
Physical properties
The Schiff bases (HLI-HLa) (Fig. 1) were prepared by refluxing an appropriate amount of 5-hydroxy-, nitro-,
methoxy- or bromo-substituted 2-aminopyridine and salicylaldehyde in hot ethanol in l:l molar ratio
respectively. The structures of these Schiff bases were established with the help of their IR, NMR, and
microanalytical data (Tables and 2)
These Schiff bases were then used for the complexation with Co(II), Cu(II), Ni(II) and Zn(II) ions. All of the
synthesized metal complexes [(1)-(16)] (Table 3) were air and moisture stable. These were prepared by the
stoichiometric reaction of the corresponding metal salts (as chlorides) and the Schiff base in molar ratios M:L
of 1:2. The complexes are intensely colored, amorphous solids, which decompose above 200 C. They are
insoluble in common organic solvents such as ethanol, methanol, chloroform or acetone, but soluble in
DMSO and DMF. Molar conductance values of the soluble complexes in DMF showed low values (12-19
ohmcmZmol) indicatings them to be non-electrolytic.
Table I. Physic
Schiff base
HL
C12HIoN202
[214.0]
HL
C12H9N303
[243.0]
HL
C13HI2N202
[228.0]
HL
CI2HsBrN20
[275.9]
al, spectral and analytical data of the Schiffbases
IR (cm) Calc (Found) % M.P
C H N (C)
3425 (br, Ph-OH), 3432 118
126
(br, Py-OH), 1630 (s,
H.C=N), 1620 (s, .C=N).
3430 (br, OH), 1635
(s, HC=N), 1620 (s,
C=N).
3430 (br, OH), 1635
(s, HC=N), 1625 (s,
C=N).
3430 (br, OH), i635
(s, HC=N), 1625 (s,
C:N).
s=sharp, br=broad
67.3 4.7 13.1
(67.8) (4.5) (13.0)
59.3 3.7 17.3
(59.5)(3.9)(17.5)
68.4 5.2 12.3 137
(68.3) (5.5)(12.0)
52.2 2.9 10.1 148
(52.6)(3.2)(10.3)
Yield
(%)
78
70
75
74
Infrared spectra
IR spectra of the Schiff bases showed the absence of bands at 1735 and 3420 cm
"l due to cat;bonyl v(C=O)
and v(NH2) stretching vibrations and, instead, appearance of a strong new band at-1635 cm" assigned
5 to
the azomethine, v(HC=N) linkage. It suggested that amino and aldehyde moieties of the starting reagents are
absent and have been converted into the azomethine moiety (Fig.l). The comparison of the IR spectra of the
Schiff bases and their metal chelates (Table 4) indicated that the Schiff bases were principally coordinated to
the metal atom in three ways, representing thus the ligands acting in a tridentate manner.
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Table 2. H and 3CNMR data of the Schiffbases
Schiff base
HL
13
14
15
16
HNMR
(DMSO-d6) ppm
7.3 (s, 1H, CH=N), 6.8 (m, H, Ph), 7.3
(m, 1H, Ph), 7.4 (m, 1H, Ph), 7.6 (m, 1H,
Py), 7.7 (m, H, Ph), 7.9 (m, H, Py), 8.4
(m, 1H, Py), 9.9 (s, 1H, Ph-OH), 10.2 (s,
H, OH, Py-OH).
J3C NMR
(DMS0-d6) ppm
115.5, 126.5, 127.2, 130.3, 148.6,
155.1 (Ph), 150.7 (C=N),140.2,
149.3, 149.8, 155.2, 160.5 (Py).
7.3 (s, IH, CH=N), 7.5 (m, 1H, Ph), 7.6 115.4, 126.6 127.1, 130.5, 148.5,
155.2 (Ph), 150.8 (C=N),140.3,
149.5, 149.8, 155.3, 160.7 (Py).
22.4 (OCH3), 115.5, 126.7, 127.5,
130.2, 148.4, 155.1 (Ph), 150.6
(C=N), 140.2, 149.6, 149.7, 155.3,
160.6 (Py).
115.6, 126.6, 127.2, 130.5, 148.6,
155.3 (Ph), 150.8 (C=N),140.4,
149.7, 149.8, 155.4, 160.7 (Py).
115.6, 126.5, 127.3, 130.5, 148.6,
155.2 (Ph), 150.9 (C=N),140.4,
149.5, 149.8, 155.3, 160.5 (Py).
115.5, 126.7, 127.2, 130.5, 148.6,
155.3 (Ph), 150.9 (C=N),140.5,
149.5, 149.8, 155.4, 160.7 (Py).
22.6 (OCHi), 115.6, 126.7, 127.7,
130.4, 148.4, 155.3 (Ph), 150.8
(C=N), 140.3, 149.6, 149.8, 155.4,
160,7 (Py).
115.7, 126.6, 127.5, 130.3, 148.7,
155.4 (Ph), 150.9 (C=N),140.4,
149.5,149.7, 155.5, 160.7 (Py).
(m, H, Ph), 7.7 (m, H, Py), 7.8 (m, IH,
Ph), 7.9 (m, H, Ph), 8.1 (m, 1H, Py), 8.4
(m, IH, Py), 10.1 (s, IH, Ph-OH).
3.6 (s, 3H, OCH3, 7.3 (s, 1H, CH=N), 7.4
(m, H, Ph), 7.6 (m, H, Ph), 7.8 (m, H,
Ph), 7.9 (m, H, Py), 8.3 (m, H, Py), 8.4
(m, 1H, Py), 10.2 (s, 1H, PhrOH).
7.3 (s, U, CH=N), 7.5 (m, 1H, Ph), 7.7
(m, 1H, Ph), 7.8 (m, 1H, Ph), 7.9 (m, H,
Ph), 8. (m, 1tt, Py), 8.3 (m, 1H, Py), 8.4
(m, H, Py), 10.2 (s, H, Ph-OH).
7.3 (s, 1H, CH=N), 6.9 (m, 1H, Ph), 7.4
(m, H, Ph), 7.5 (m, 1H, Ph), 7.6 (m, H,
Py), 7.8 (m, 1H, Ph), 8.1 (m, 1H, Py), 8.4
(.m, H, Py), 10.2 (s, 1H, OH, Py-OH).
7.4 (s, H, CH=N), 7.6 (m, 1H, Ph), 7.7
(m, 1H, Ph), 7.8 (m, H, Py), 7.9 (m, IH,
Ph), 8.0 (m, 1H, Ph), 8.1 (m, H, Py), 8.4
(m, 1H,.. Py).
3.7 (s, 3H, OCH3, 7.4 (s, 1H, CH--N), 7.5
(m, H, Ph), 7.7 (m, 1H, Ph), 7.8 (m, H,
Ph), 8.1 (m, 1H, Py), 8.3 (m, H, Py), 8.6
(m, 1H, Py).
7.5 (s, 1H, CH=N), 7.6 (m, ill, Ph), 7.8
(m, H, Ph), 7.9 (m, 1H, Ph), 8.1 (m, 1H,
Ph), 8.2 (m, H, Py), 8.3 (m, H, Py), 8.5
(m, IH, Py).
a)
b)
c)
d)
The band appearing at 1635 cm due to the azomethine was shifted to lower fi’equency by -10-15
cm" Indicating participation of the azomethine nitrogen in the complexation.
The band at 1620 assigned to pyridine ring v(C=N) nitrogen also shifted to lower frequency by -15-
25 cm" which was indicative of the involvement of ring nitrogen of pyridine in chelation.
A band appearing at 3425 cm assigned to v(OH) in the Schiff base compounds was not found in
the spectra of their metal complexes indicating deprotonation and coordination of the hydroxyl
oxygen to the metal atom.
Further conclusive evidence of the coordination of these Schiff base compounds with the metals,
was shown by the appearance of weak low frequency new bands at 525-530 and 455-460 cm . These
were assigned
5 to the metal-nitrogen v(M-N) and metal-oxygen v(M-O) respectively. These new
bands were observable only in the spectra of the metal complexes and not in the spectra of its
uncomplexed Schiff base compounds thus confirming participation of these hetero groups (O or N)
in the coordination.
NMR spectra
The IH NMR spectra of the Schiff bases and of their Zn(II) complexes taken in DMSO-do are listed in Table
2. The Schiff bases exhibited signals due to all the expected protons in their expected region and have been
identified from the integration curve found to be equivalent to the total number of protons deduced from their
proposed structures. These were compared with the reported
54 signals of the known identical compounds and
give further support for the compositions of the new ligands as well as their complexes suggested by their IR
and elemental analyses data. Comparison of the chemical shifts of the uncomplexed Schiff bases with those
of the corresponding complex show that some of the resonance signals experience shifts upon the
complexation. In each case, the protons assigned due to heteroaromatic (HC=N), azomethine (HC=N),
139Zahid H. Chohan et al. Transition Metalion Complexes ofSchfff-Bases. Synthesis,
Characterization and Antibacterial Properties
hydroxyl group (OH) and substituted aromatic were found at around 8.8, 7.3, 9.9 and 6.8-7.7 ppm in the
spectra of the ligands. The protons due to heteroaromatic, azomethine and substituted aromatic undergo shift
towards downfield by 0.9-1.0 ppm in the complexes indicating coordination of these groups with the metal
atom. Also, protons due to hydroxyl group (OH) were found absent in the spectra of the complexes. The
absence of these signals suggested
55 the deprotontion of the hydroxyl group and the involvement of the
oxygen atom in complexation.
Table 3. ical and
No Metal chelate/
Mol. Formula
[Co(L’),] [484.9]
C24H 18oN404
2 [Co(L-’)] [542.9]
C,,H,,,CoNO6
3 [(20(L)2] [512.9]
C H CoN O
4 [Co(L ),] [584.7]
C H CoBr,N O 22
5 [Cu(L ),] [489.5]
C H CuN O
6 [Cu(L-)2] [547.5]
C H CuN O 2d I 6
[Cu(L)d
C26H2CuN,O.
8 [Cu(L )] [589.3]
C2HCuBr2N40,
9 [Ni(L’)2] [484.]
,(C*),] [42.7] 10
C,H,,iN606 [(L)] [e.7]
C.HiN,Q
e [I(U)=] [84.]
C2H 4NiBreN40:
13 [Zn L’)e] [491.4]
C24HsZnN40
14 [Zn(L)e] [549.4]
C24HI6ZnN606
15 [Zn(U)e] [519.4]
C26H22ZnN40.
16 [Zn(L")] [591.2]
C22H4ZnBrN40
data of the metal(ll) chelates
Yield M.P (C) B.M.
(%) (decomp) (Felt)
60 218-220 4.2
56 220-222 4.7
58 221-223 4.5
61 225-227 4.3
57 218-220 ’116’
58 228-230 1.4
58 2i’2-214 1.5
60 226-228 1.4
61 220-222 3.3
56 225-228 3.1
58 228-230 3.4
60 ’222-224 3.2’
60 215-217 Dia
58 2182220 Dia
61 222-224 Dia
62 225-227 Dia
Calc (Found)%
C H N
59.’4 3.7 1[.5
(59.1) (3.3)(11.9)
53.0 .2.9 15.5
(53.4) (2.4) (15.4).
60.8 4.3 10.9
(60.7) (4.1) (10.5)
45.2 2.4 9.6
(45.6) (2.3)(9.8)
58.8 3.7 11.4
(58.7) (3.5)(11.2)
52.6 2.9 15.3
(52.5) (2.5) (15.4)
60.3 4.3 10.8
(60.5). (4.5) (10.4)
44.8 2.4 9.5
(45.1)(2.2)(9.3)
59.4 3.7 11.5
(59.5) (3.4)(11.3)
53.1 2.9 15.5
(53.4)(2.7)(15.4)
60.9 4.3 11.0
(60.7) (4.5). (11.3)
45.2 2.4 9.6
(45.5) (2.3)(9.8)
58.6 3.7 11.4
(58.9) (3.4)(11.3)
52.4 2.9 15.3
(52.7) (2.5) (15.1)
60.1 4.2 10.8
(60.2) (4.3) (10.5)
44.7 2.4 9.5
(44.5) (2.3)(9.7)
Magnetic moments and UV-visible spectra
The room temperature magnetic moment of the solid cobalt (II) complexes was found to lie in the range (4.2-
4.7 B.M), indicative
52 of three unpaired electrons per Co (II) ion in an octahedral environment. The Cu (lI)
complexes showed ve values in the range (1.4-1.6 B.M) indicative of one unpaired electron per Cu (II) ion
suggesting
56 these complexes within the range consistent to spin-free distorted octahedral 8eometry.
Similarly the In (II) complexes showed ve values in the range (3.1-3.4 B.M), corresponding
7 to two
unpaired electrons per Zn(II) ion for their ideal six-coordinated configuration. The Zn(II) complexes were all
found diamagnetic.
The electronic spectra of the Co(II) chelates sowed Ihree barjds observed at 878-8815,417560-18425 and
,-I., 30210-30575 cm which may be assigned to T, --+ T,(F), T,g -+ A,g(F) and T,g -+ Tg(P) transitions
55859 respectively and are suggestive of the octahedral geometry around the cobalt ions.
The Cu(ll) complexes showed three absorption bands between 10 Dq band for a distorted octahedral
geometry corresponding
6’6 to the transitions 2Eg -+2T28. The bands at 22152-22355 and 30550-30645 cm
may be due to intra-ligand charge transfer transitions.
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The Ni(II) complexes exhibited three spin-allowegt bands at 815-10145,.5945-16250 and 28540-2910 cm"
signable6263respectively, to the transitions aA,g(F) ’T2g(F)(v), "Ag(F)’T(F)(v2) and "Ag(F)
---> T3(P)(v3) which were characteristic of their octah-edral geometry (Fig 2).
Table 4. IR and UV-visible.. spectral data of the metal(II) chelates
R tcm "), No
10
11
12
13
14
15
16
1625 (s, HC=N), 1580 (s, =N), 525 (ms, M-N),.455 (ms, M-O)
1620 (s, HC=N), .1585 (s, C=N), 525 (ms, M-N),.455 (ms, M-O)
1620 (,s, HC=N), ...1590 (s, C=N), 530 (ms, M-N), 460 (ms; M-O)
!..620 (s, HC=N), .1590 (S, C N), 530 (ms, M-N), 460 (ms, M,O)..
1625 (s, HC=N), 1585 (s, C N), 525 (ms, M-N), 460 (ms, M-0)
1620 (s, HC=N), 1580 (s, C=N), 530 (ms, M-N), 455 (ms, M-O)
kmax (cm "1)
30210, 18425, 8815
30575,17850,8795
3545,17950,8810
30550,17560,8780
30565(22255
30575,22350
30645,22265
30550,22180
28540,16275,98i5
29210,15945,1’0145"
28875,1d250,9980
1625. (s, HC=N), 1585 (s, C=N).: 525 (ms, M-N), 460 (ms, M-O)
1625. (s, FIC=N), .1585 (s, C=N), 530 (ms, M-N), 455 (ms, M-O)
1620 (s, HC=N), 1580 (s, C=N)., 525 (m..s, M-N), 455 (ms, M-O)
1620 (s, HC=N), ..1585 (s, C=N), 525 (ms, M-N),.460 (ms, M-O)
1625 (s, HC=N), 1590 (s, C=N), 530 (ms, M-N), 460 (ms, M-O)
1620 (s, HC=N), 1585 (s,.C=N), 525.(ms, M,N),. 455 (ms, M-O)
1625 (s, HC=N), 1590 (s, C=N), 530 (ms, M-N), 455 (ms M-O)
1625 (s, HC=N), 1595 .(s, C=N)., 530 (ms, M-N), 460 (ms, M-O)
1620 (s, HC=N), 1585 (s, C=N), 525 (ms, M-N), 460 (ms, M-O)
1625 (s, HC=N), 1585 (s, C=N), 525.(ms, M-N), 455 (ms, M-O)
28910, 16155, 9875
28450
28510
28475
2850O
s=sharp, ms=medium sharp
The diamagnetic zinc(II) complexes did not show any d-d bands and their spectra are dominated only
by charge transfer bands. The charge transfer band at 28450-28510 cm
l was assigned
6364 due to transition
-E -+ -T2 possibly n an octahedral environment.
NCH
CH 0 )
R=OH (IlL )
R=NO., (HL 2)
R=OCH (HL 3)
R=Br (HL 4)
M=Co(II), Cu(II), Ni(ll) or Zn(ll)
(Fig. 2) Proposed structure of the metal(II) complex
Antibacterial properties
The title Schiff bases and their metal chelates were evaluated for their antibacterial activity against the strains
Escherichia coli (a), Staphylococcus aureus (b) and Pseudomonas aeruginosa (c). The compounds were
tested at a concentration of 30 lag/0.01 mL in DMF solution using the paper disc diffusion method. The
susceptibility zones were measured in diameter (mm) and the results are reproduced in Table 5. The
susceptibility zones measured were the clear zones around the discs killing the bacteria.
All the Schiff bases and their complexes individually exhibited varying degrees of inhibitory effects on the
growth of the tested bacterial species. The antibacterial results evidently show that the activity of the Schiff
base compounds became more pronounced when coordinated to the metal ions. All metal ions have varying
antibacterial influence on bacterial species. The Co(II) complex of HLI was more antibacterial against one
species and less against the other as compared to the Co(II) complex of the other Schiff bases. Same results
were found for other metal complexes. It is however, not possible to make out exactly which metal ion is
playing more antibacterial role against one or the other bacterial species but, it is definitive that metal ions do
play a significant role in enhancing the antibacterial activity of antibacterial agents on chelation. It is
suggested that in the chelated complex, the positive charge of the metal ion is partially shared with the donor
atoms and there is g-electron delocalization over the whole chelate ring. This increases the lipophilic
character of the metal chelate and favors its permeation through lipoid layers of the bacterial membranes. It is
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also suspected that factors such as solubility, dipole moment and cell permeability mechanisms are also
influenced by the presence of the metal ions, which are responsible in enhancing this role of metals as
bactericidal. Our in vitro studies are in progress, which would help us in determining further the actual
mechanism involved in enhancing this activity.
Table 5. Antibacterial activity data of the Schiff bases and its metal(II) chelates
SchiffBase/
Chelate
HL’
HL.2
HL
HL
2
3
Micro
a
++
,,+
,+++
+++
+++
+++
+++
’++++
b ial S pecies
++
++
++
+++
++
+++
+++
++
+++
+++
4 +++ +++
5 +++ +++ +++
6 +++/ ++ +++
7 ++ +/ +
8 +++ +++ +++
9 ++/ ’+++ +++
10 +++
+++
+++
+++
++
++++
+++
++++
++/
+++
++
+++
++
+++ ++
15 +++ +++ ++
16 +++ +++ +++
’a"-’ scherichia coli, b Staphylococcus aureus, c Pseudomonas aeruginosa
Inhibition zone diameter mm (% inhibition): +, 6-10 (27-45 %); ++, 10-14
(45-64 %); +++, 14-18 (64-82 %); ++++, 18-22 (82-100 %). Percent inhibition values are
relative to inhibition zone (22 mm) of the most active compound with 100 % inhibition.
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